CIK 0001829802 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -21.1 M | -34.1 M | -48.6 M |
| Diluted EPS (USD/shares) | -16.72 | -1.22 | -1.58 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-17 | 8-K | 8-K items 5.02 | 2026-09-11 |
| 2026-09-15 | 4 | 4 | 2026-09-11 |
| 2026-09-15 | 3 | 3 | 2026-09-11 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-11 | 144 | 144 | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-07-28 | 3 | 3 | 2026-06-15 |
| 2026-07-23 | 8-K | 8-K items 5.02 | 2026-07-21 |
| 2026-07-23 | 4 | 4 | 2026-07-21 |
| 2026-07-23 | 4 | 4 | 2026-07-21 |
| 2026-07-01 | 4 | 4 | 2026-06-29 |
| 2026-06-26 | 4 | 4 | 2026-06-24 |
| 2026-06-24 | 4 | 4 | 2026-06-22 |
| 2026-06-24 | 4 | 4 | 2026-06-22 |
| 2026-06-23 | 3 | 3 | 2026-06-13 |
| 2026-06-23 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-23 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-18 | 8-K | 8-K items 1.01,8.01,9.01 | 2026-06-15 |
| 2026-06-18 | S-3ASR | S-3ASR | |
| 2026-06-16 | 4 | 4 | 2026-06-12 |
| 2026-06-16 | 4 | 4 | 2026-06-15 |
Forms on file (last 1,000): 4 197, 8-K 83, 3 30, 10-Q 17, 4/A 13, DEFA14A 9, 144 8, SCHEDULE 13G 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=FTH (0.002 USD), /gw/filings/filings?ticker=FTH&form=8-K, /gw/filings/facts?ticker=FTH&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange